EP0491330A1 - Procédé pour la préparation de l'acide diméthylcyclopropanecarboxylique - Google Patents
Procédé pour la préparation de l'acide diméthylcyclopropanecarboxylique Download PDFInfo
- Publication number
- EP0491330A1 EP0491330A1 EP91121549A EP91121549A EP0491330A1 EP 0491330 A1 EP0491330 A1 EP 0491330A1 EP 91121549 A EP91121549 A EP 91121549A EP 91121549 A EP91121549 A EP 91121549A EP 0491330 A1 EP0491330 A1 EP 0491330A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- ester
- acid
- base
- preparation
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- VEQMUQZKBLIXLT-UHFFFAOYSA-N 2,3-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1C(C)C1C(O)=O VEQMUQZKBLIXLT-UHFFFAOYSA-N 0.000 title 1
- XUYJLQHKOGNDPB-UHFFFAOYSA-N phosphonoacetic acid Chemical compound OC(=O)CP(O)(O)=O XUYJLQHKOGNDPB-UHFFFAOYSA-N 0.000 claims abstract description 25
- GELKGHVAFRCJNA-UHFFFAOYSA-N 2,2-Dimethyloxirane Chemical compound CC1(C)CO1 GELKGHVAFRCJNA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims abstract description 3
- 150000002148 esters Chemical class 0.000 claims description 16
- 239000002585 base Substances 0.000 claims description 12
- 238000010931 ester hydrolysis Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 3
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims description 2
- 229910000102 alkali metal hydride Inorganic materials 0.000 claims description 2
- 150000008046 alkali metal hydrides Chemical class 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 239000002253 acid Substances 0.000 abstract description 6
- RSYOSUMAMNFKSM-UHFFFAOYSA-N 2-[(7-chloroquinolin-4-yl)amino]ethanol Chemical compound ClC1=CC=C2C(NCCO)=CC=NC2=C1 RSYOSUMAMNFKSM-UHFFFAOYSA-N 0.000 abstract description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 10
- -1 2,2-dimethylcyclopropanecarboxylic acid ester Chemical class 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000009835 boiling Methods 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- 229940078552 o-xylene Drugs 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- MTZWHHIREPJPTG-UHFFFAOYSA-N phorone Chemical compound CC(C)=CC(=O)C=C(C)C MTZWHHIREPJPTG-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- PBIJFSCPEFQXBB-UHFFFAOYSA-N 1,1-dimethylcyclopropane Chemical class CC1(C)CC1 PBIJFSCPEFQXBB-UHFFFAOYSA-N 0.000 description 1
- CZPCJHBAFHCDRE-UHFFFAOYSA-N 2,2-dimethylcyclopropane-1-carbonitrile Chemical compound CC1(C)CC1C#N CZPCJHBAFHCDRE-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- DHSUYTOATWAVLW-WFVMDLQDSA-N cilastatin Chemical compound CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O DHSUYTOATWAVLW-WFVMDLQDSA-N 0.000 description 1
- 229960004912 cilastatin Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- OAPHLAAOJMTMLY-UHFFFAOYSA-N ethyl 2-methylbut-2-enoate Chemical compound CCOC(=O)C(C)=CC OAPHLAAOJMTMLY-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- HHXMXAQDOUCLDN-RXMQYKEDSA-N penem Chemical compound S1C=CN2C(=O)C[C@H]21 HHXMXAQDOUCLDN-RXMQYKEDSA-N 0.000 description 1
- 150000003018 phosphorus compounds Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- GHKGUEZUGFJUEJ-UHFFFAOYSA-M potassium;4-methylbenzenesulfonate Chemical compound [K+].CC1=CC=C(S([O-])(=O)=O)C=C1 GHKGUEZUGFJUEJ-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- SWGMKWQNFIOGDY-UHFFFAOYSA-N propan-2-yl 2-diethoxyphosphorylacetate Chemical compound CCOP(=O)(OCC)CC(=O)OC(C)C SWGMKWQNFIOGDY-UHFFFAOYSA-N 0.000 description 1
- DNXIASIHZYFFRO-UHFFFAOYSA-N pyrazoline Chemical compound C1CN=NC1 DNXIASIHZYFFRO-UHFFFAOYSA-N 0.000 description 1
- 150000003219 pyrazolines Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
Definitions
- the invention relates to a new process for the preparation of R, S-2,2-dimethylcyclopropanecarboxylic acid, which is abbreviated below as R, S-2,2-DMCPCS.
- R, S-2,2-DMCPCS is an important intermediate for the production of S - (+) - 2,2-dimethylcyclopropanecarboxamide (hereinafter abbreviated as S - (+) - 2,2-DMCPCA), R, S-2 , 2, DMCPCS is converted into the optically pure S - (+) - enantiomer by racemate resolution and is subsequently converted into the S - (+) - 2,2-DMCPCA via acid chloride (Lit .: EP 093 511).
- S - (+) - 2,2-DMCPCA in turn serves as the starting material for the production of the dehydropeptidase inhibitor cilastatin, which is administered in therapy together with penem or carbapenem antibiotics in order to deactivate the antibiotics by a renal dehydropeptidase in the To prevent kidney (Lit .: EP 048 301).
- a major disadvantage of this process is that large amounts of potassium tosylate are obtained as waste products for disposal and moderate yields (28%) are achieved.
- a major disadvantage of this process is that the 2,2-dimethylcyclopropanecarboxylic acid ester is obtained in very poor yield (9%) and the overall yield of the corresponding acid is therefore even lower.
- Another disadvantage of this process is the use of the expensive sulfur ylide derivative.
- R, S-2,2-DMCPCS Another process for the production of R, S-2,2-DMCPCS is described in DE-PS 27 51 133.
- the 4-chloro-4,4-dimethylbutyric acid ester is first prepared from a lactone derivative and this is cyclized in the presence of alcoholates to give the R, S-2,2-dimethylcyclopropanoic acid ester, which is subsequently hydrolyzed.
- a major disadvantage of this process is that the lactone is not commercially available and has to be prepared in a multi-stage synthesis.
- the object of the invention was to eliminate these disadvantages and to provide a simple and economical process for the preparation of R, S-2,2-dimethylcyclopropanecarboxylic acid, the R, S-2,2-DMCPCS being obtained in good yields.
- the process is carried out in such a way that isobutylene oxide of the formula with a phosphonoacetic acid trialkyl ester of the formula wherein R1, R2 and R3 are the same or different and are a C1-C4 alkyl group, branched or unbranched, in the presence of a base in an R, S-2,2-dimethylcyclopropanecarboxylic acid C1-C4 alkyl ester of the general formula wherein R3 has the meaning given, converted, and hydrolyzed the ester to the end product in the presence of a base.
- the phosphonoacetic acid trialkyl esters can be obtained by reacting a trialkoxyphosphine with a halogenoacetic acid ester (Houben-Weyl, Methods of Organic Chemistry, 4th Edition, Volume: Phosphorus Compounds I, pp. 173-176).
- phosphonoacetic acid trialkyl ester is phosphonoacetic acid triethyl ester or diethylphosphonoacetic acid isopropyl ester.
- Phosphonoacetic acid triethyl ester is preferably used.
- the reaction of the phosphonoacetic acid trialkyl ester with isobutylene oxide is carried out in the presence of a base.
- a base An alkali metal hydride such as sodium hydride, potassium hydride or lithium hydride can be used as the base, for example.
- the base is expediently used in equimolar amounts to the phosphonoacetic acid trialkyl ester.
- the reaction temperature is advantageously between 100 and 140 ° C, preferably between 110 and 130 ° C.
- High-boiling aromatic hydrocarbons or polar solvents can be used as solvents.
- xylene or xylene isomer mixtures can be used as high-boiling aromatic hydrocarbons.
- Glycol ethers, such as diethylene glycol dimethyl ether, for example, can be used as the polar solvent.
- a high-boiling aromatic hydrocarbon, such as, for example, o-xylene, is preferably used as the solvent.
- R, S-2,2-dimethylcyclopropanecarboxylic acid C1-C4 alkyl ester is then conveniently hydrolyzed without isolation, in the presence of a base to the desired R, S-2,2-DMCPCS.
- An alkali metal hydroxide is expediently used as the base for the ester hydrolysis.
- Sodium hydroxide or potassium hydroxide for example, can be used as the alkali hydroxide.
- ester hydrolysis is expediently carried out with 1 to 2 mol of base, preferably with 1.2 to 1.5 mol, based on 1 mol of R, S-2,2-dimethylcyclopropanecarboxylic acid ester.
- the ester hydrolysis is expediently carried out at a temperature of from 40 ° C. to the reflux temperature of the solvent used, preferably at the reflux temperature.
- the ester hydrolysis is expediently carried out in a mixture of one of the high-boiling aromatic hydrocarbons mentioned with an aqueous alcoholic solution.
- Lower alcohols such as, for example, methanol or ethanol, can be used as alcohols.
- the R, S-2,2-dimethylcyclopropane carboxylic acid can be isolated after a reaction time of 2 to 3 hours, for example by acidifying the reaction mixture and subsequent extraction.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH3991/90 | 1990-12-17 | ||
CH399190 | 1990-12-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0491330A1 true EP0491330A1 (fr) | 1992-06-24 |
EP0491330B1 EP0491330B1 (fr) | 1995-03-22 |
Family
ID=4267768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP91121549A Expired - Lifetime EP0491330B1 (fr) | 1990-12-17 | 1991-12-16 | Procédé pour la préparation de l'acide diméthylcyclopropanecarboxylique |
Country Status (9)
Country | Link |
---|---|
US (1) | US5149869A (fr) |
EP (1) | EP0491330B1 (fr) |
JP (1) | JPH04266844A (fr) |
AT (1) | ATE120178T1 (fr) |
CA (1) | CA2056840A1 (fr) |
DE (1) | DE59105000D1 (fr) |
DK (1) | DK0491330T3 (fr) |
ES (1) | ES2069809T3 (fr) |
NO (1) | NO175588C (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2124714T3 (es) * | 1991-07-26 | 1999-02-16 | Lonza Ag | Procedimiento de ingenieria genetica para la preparacion de s-(+)-2,2-dimetilciclopropanocarboxamida mediante microorganismos. |
NZ529625A (en) * | 2001-05-18 | 2006-02-24 | Ranbaxy Lab Ltd | Process for the preparation of amorphous cilastatin sodium |
GB0615620D0 (en) * | 2006-08-05 | 2006-09-13 | Astrazeneca Ab | A process for the preparation of optically active intermediates |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2751133A1 (de) * | 1977-11-16 | 1979-05-17 | Degussa | Verfahren zum cyclisieren von gamma-chlorcarbonsaeureestern |
EP0048301A1 (fr) * | 1980-09-24 | 1982-03-31 | Merck & Co. Inc. | 2-(Cyclopropancarboxamido)-2-alcèneacides, leurs esters et sels, et compositions bactériostatiques à base de ces composés avec un composé du type thiénamycine |
US4542235A (en) * | 1982-04-12 | 1985-09-17 | Sumitomo Chemical Company, Limited | Method for producing an optically active 2,2-dimethylcyclopropanecarboxylic acid |
-
1991
- 1991-12-03 CA CA002056840A patent/CA2056840A1/fr not_active Abandoned
- 1991-12-06 US US07/803,066 patent/US5149869A/en not_active Expired - Fee Related
- 1991-12-12 JP JP3329109A patent/JPH04266844A/ja not_active Withdrawn
- 1991-12-16 AT AT91121549T patent/ATE120178T1/de active
- 1991-12-16 DK DK91121549.9T patent/DK0491330T3/da active
- 1991-12-16 NO NO914965A patent/NO175588C/no unknown
- 1991-12-16 DE DE59105000T patent/DE59105000D1/de not_active Expired - Fee Related
- 1991-12-16 ES ES91121549T patent/ES2069809T3/es not_active Expired - Lifetime
- 1991-12-16 EP EP91121549A patent/EP0491330B1/fr not_active Expired - Lifetime
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS, Band 68, Nr. 5, 29 Januar 1968, Columbus, Ohio, USA, S. R. LANDOR et al., "Cyclopropanes from alpha, beta-unsaturated esters by the dimithylsulfoxonium methylide reaction", Seite 2058, abstract-nr. 21 563e; & J. Chem. Soc., C 1967, vol. 23, pages 2495-2500 (Eng). * |
PATENT ABSTRACTS OF JAPAN, unexamined applications, E Field, Band 7, Nr. 285, 20 Dezember 1983, THE PATENT OFFICE JAPANESE GOVERNMENT, Seite 164 C 201; & JP-A-58 164 542 (SUMITOMO). * |
Also Published As
Publication number | Publication date |
---|---|
US5149869A (en) | 1992-09-22 |
CA2056840A1 (fr) | 1992-06-18 |
ATE120178T1 (de) | 1995-04-15 |
DE59105000D1 (de) | 1995-04-27 |
EP0491330B1 (fr) | 1995-03-22 |
NO914965D0 (no) | 1991-12-16 |
JPH04266844A (ja) | 1992-09-22 |
NO175588B (no) | 1994-07-25 |
ES2069809T3 (es) | 1995-05-16 |
NO175588C (no) | 1994-11-02 |
DK0491330T3 (da) | 1995-04-18 |
NO914965L (no) | 1992-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1935386C3 (de) | Optisch aktive innere Hemiacylale von cis-33-Dimethyl-2-formyl-cyclopropan-1-carbonsäuren und Verfahren zu ihrer Herstellung sowie deren Racematen | |
DE3817956A1 (de) | Verfahren zur herstellung phosphorhaltiger l-aminosaeuren sowie ihrer ester und n-derivate | |
CH624920A5 (en) | Process for the preparation of trans-2,2-dimethyl-3-(2,2-dichloroethenyl)cyclopropane-1-carboxylic acid and its esters | |
DE2418715C2 (de) | Allensäureester | |
DE2751133A1 (de) | Verfahren zum cyclisieren von gamma-chlorcarbonsaeureestern | |
EP0491330B1 (fr) | Procédé pour la préparation de l'acide diméthylcyclopropanecarboxylique | |
DE2605398C3 (de) | Verfahren zur Herstellung von ß -Dihalogenäthenylcyclopropancarbonsäure-Derivaten | |
DE2621835A1 (de) | Verfahren zur herstellung von cyclopropancarbonsaeurederivaten | |
DE2404159C2 (de) | Verfahren zur Herstellung von 2-(4-Alkylphenyl)-propionsäuren und ihren Natrium-oder Kaliumsalzen | |
CH636593A5 (de) | Verfahren zur herstellung von gamma-chlorcarbonsaeureestern. | |
DE2533396C2 (de) | 3-Methyl-3-aryl-brenztraubensäureester und Verfahren zu ihrer Herstellung | |
DE2721265C2 (de) | Verfahren zur Herstellung von Di- n-propylacetonitril | |
DE1959401C3 (de) | Verfahren zur Herstellung von in 2-Stellung substituierten trans-33-Dimethyl-cyclopropan-1 -carbonsäuren | |
DE2238921C3 (de) | Verfahren zur Herstellung von 0,0-Dialkyl-0-(2,2-dichlorvinyl)-thionophosphorsäureestern | |
EP0103749B1 (fr) | Dialcoxyméthyl-butyrolactones, procédé et intermédiaires pour leur préparation et leur utilisation | |
DE2024614C3 (de) | Neues Verfahren zur Herstellung von d-trans-Pyrethrinsäure-(1R.2R) | |
EP0606058A2 (fr) | Acides cinnamiques halogénés et leurs esters ainsi que des procédés pour leur préparation et sels aryldiazonium halogénés | |
DE2552615A1 (de) | Verfahren zur herstellung von dihalogenvinylcyclopropancarboxylaten | |
DE2260447C3 (de) | Verfahren zur Herstellung von Methyljasmonat | |
WO2022184612A1 (fr) | Procédé de préparation d'alkyl-4-oxotétrahydrofuran-2-carboxylate | |
EP0098945B1 (fr) | Procédé de préparation d'énantiomères purs de méthyljasmonate | |
DE1543423A1 (de) | Verfahren zur Herstellung von 2-Methylencycloalkancarbonsaeuren und deren Derivaten | |
WO2000009469A1 (fr) | Procede permettant de fabriquer un ethylester d'acide atropique | |
DE4331000A1 (de) | Verfahren zur Herstellung von Pimelinsäureestern | |
DE3046059C2 (de) | 4-Halogen-5,5-dialkoxypentansäureester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von 2,2-Dialkyl-3-formylcyclopropancarbonsäureestern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE |
|
17P | Request for examination filed |
Effective date: 19921221 |
|
17Q | First examination report despatched |
Effective date: 19940330 |
|
ITF | It: translation for a ep patent filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE |
|
REF | Corresponds to: |
Ref document number: 120178 Country of ref document: AT Date of ref document: 19950415 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19950327 |
|
REF | Corresponds to: |
Ref document number: 59105000 Country of ref document: DE Date of ref document: 19950427 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2069809 Country of ref document: ES Kind code of ref document: T3 |
|
ET | Fr: translation filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19951124 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 19951208 Year of fee payment: 5 Ref country code: BE Payment date: 19951208 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19951211 Year of fee payment: 5 Ref country code: AT Payment date: 19951211 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19951213 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 19951215 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19951227 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19960118 Year of fee payment: 5 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19960328 Year of fee payment: 5 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19961216 Ref country code: DK Effective date: 19961216 Ref country code: AT Effective date: 19961216 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19961217 Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 19961217 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Effective date: 19961231 Ref country code: CH Effective date: 19961231 Ref country code: BE Effective date: 19961231 |
|
BERE | Be: lapsed |
Owner name: LONZA A.G. Effective date: 19961231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19970701 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19961216 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Effective date: 19970829 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 19970701 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19970902 |
|
EUG | Se: european patent has lapsed |
Ref document number: 91121549.9 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20010301 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051216 |